VanEck Pharmaceutical ETF · $1.1B$17,424
PPHPPH vsSPYSPYState Street SPDR S&P 500 ETF · $819B$17,118
$10,000 five years ago, dividends reinvested · they hold 5.0% in common
PPHMeasureSPY
Returns · dividends reinvested
+17.2%Year to dateJan 1 → Nov 6+8.7%
+29.4%1 yearTotal return+9.7%
+18.7%3 years · per year$10,000 became $16,725 · $18,039+21.7%
+11.7%5 years · per year$10,000 became $17,424 · $17,118+11.3%
Cost and income
0.36%Expense ratio$36 · $9 a year on $10k · lower is better0.09%
1.80%Trailing 12-mo yield$180 · $103 a year on $10k1.03%
Risk · past year
−10.8%Worst dropSmaller is better−8.9%
18.8%VolatilityLower is calmer13.6%
PPHSPY Winner of the row, in its colourEach row: the bigger of the two fills its side
4–4Level
End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns